Income Statement (TTM)
Instil Bio, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
|
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Change (%) | -31.88 | -45.74 | -100.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | |
| Cost Of Sales | ||||
| Change (%) | ||||
| % of Revenue | ||||
| Gross Operating Profit | 0 | 0 | 0 | 0 |
| Change (%) | -31.88 | -45.74 | -100.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | |
| SG&A | 13 | 21 | 33 | 44 |
| Change (%) | 59.18 | 54.97 | 33.39 | |
| % of Revenue | 9,770.29 | 22,831.91 | 65,213.73 | |
| R&D | 18 | 31 | 50 | 74 |
| Change (%) | 66.03 | 62.50 | 49.00 | |
| % of Revenue | 13,384.78 | 32,625.53 | 97,717.65 | |
| OpEx | 32 | 52 | 83 | 119 |
| Change (%) | 63.14 | 59.40 | 42.75 | |
| % of Revenue | 23,155.07 | 55,457.45 | 162,931.37 | |
| Operating Income | -32 | -52 | -83 | -119 |
| Change (%) | 63.55 | 59.59 | 42.84 | |
| % of Revenue | -23,055.07 | -55,357.45 | -162,831.37 | |
| Interest Expense | ||||
| Change (%) | ||||
| % of Revenue | ||||
| Net Income | -38 | -57 | -83 | -119 |
| Change (%) | 50.45 | 45.99 | 43.12 | |
| % of Revenue | -27,346.38 | -60,401.06 | -162,521.57 | |
Source: Capital IQ
